181 related articles for article (PubMed ID: 32762038)
1. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea'.
Choi JW; Lee ES
Br J Dermatol; 2020 Dec; 183(6):1149-1150. PubMed ID: 32762038
[No Abstract] [Full Text] [Related]
2. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea' - reply from the authors.
Kim HS; Ahn HS
Br J Dermatol; 2020 Dec; 183(6):1150-1151. PubMed ID: 32767749
[No Abstract] [Full Text] [Related]
3. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
4. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
[TBL] [Abstract][Full Text] [Related]
5. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
6. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M
Dermatol Clin; 2017 Apr; 35(2):129-134. PubMed ID: 28317522
[TBL] [Abstract][Full Text] [Related]
7. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study.
Lee YB; Kim S; Kim HS
J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730
[No Abstract] [Full Text] [Related]
8. The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved.
Rooker A; Ouwerkerk W; Bekkenk MW; Luiten RM; Bakker WJ
J Invest Dermatol; 2024 Feb; 144(2):234-242. PubMed ID: 37791932
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the Occurrence of Melanoma and Non-melanoma Skin Cancer in Patients with Vitiligo.
Hammoud SM; Kruis RW; Sigurdsson V
Acta Derm Venereol; 2016 Jan; 96(1):106-7. PubMed ID: 26084211
[No Abstract] [Full Text] [Related]
10. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cutaneous melanoma and melanoma in situ: a 10-year nationwide retrospective cohort study in South Korea.
Soh BW; Kim YC; Choi JW
Melanoma Res; 2020 Jun; 30(3):297-302. PubMed ID: 32356958
[TBL] [Abstract][Full Text] [Related]
12. Vitiligo and skin cancer: is it a question of ethnicity?
Gran S
Br J Dermatol; 2020 Apr; 182(4):825-826. PubMed ID: 31621061
[No Abstract] [Full Text] [Related]
13. Coexisting malignant melanoma and vitiligo in a Nigerian.
Alabi GO; Falope ZF; Lekwauwa UG
West Afr J Med; 1991; 10(1):443-6. PubMed ID: 2069894
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.
Kim T; Yoon S; Shin DE; Lee SC; Oh J; Lee SY; Kim DK; Kim S; Jung B; Kim M; Lee S
Cancer Res Treat; 2022 Jul; 54(3):937-949. PubMed ID: 34607396
[TBL] [Abstract][Full Text] [Related]
15. Reduced incidence of skin cancer in patients with alopecia areata: A retrospective cohort study.
Mostaghimi A; Qureshi S; Joyce C; Guo Y; Huang KP
Cancer Epidemiol; 2016 Apr; 41():129-31. PubMed ID: 26943854
[TBL] [Abstract][Full Text] [Related]
16. Vitiligo and cutaneous melanoma. A case study.
Schallreuter KU; Levenig C; Berger J
Dermatologica; 1991; 183(4):239-45. PubMed ID: 1809584
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune, inflammatory, allergic and neuropsychiatric outcomes of offspring born to mothers with vitiligo: a nationwide Korean population-based birth cohort study.
Han JH; Ju HJ; Kang H; Lee JH; Lee S; Bae JM
Br J Dermatol; 2023 Sep; 189(4):488-490. PubMed ID: 37335952
[No Abstract] [Full Text] [Related]
18. IX. Malignant melanoma and vitiligo.
J Invest Dermatol; 1979 Nov; 73(5 Pt 2):491-4. PubMed ID: 501142
[No Abstract] [Full Text] [Related]
19. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea.
Kang H; Lee S
Clin Exp Dermatol; 2023 Apr; 48(5):484-489. PubMed ID: 36656897
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.
Quaglino P; Marenco F; Osella-Abate S; Cappello N; Ortoncelli M; Salomone B; Fierro MT; Savoia P; Bernengo MG
Ann Oncol; 2010 Feb; 21(2):409-414. PubMed ID: 19622589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
